Quinolone-associated tendonitis: A potential problem in COPD?

Irish Journal of Medical Science

Volumn 170, Issue 3, 2001, Pages 198-199

  Butler, M W ^a   Griffin, J F ^a   Quinlan, W R ^a   McDonnell, T J ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGE; AGED; ANKLE; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNICABLE DISEASE; HUMAN; KIDNEY DISEASE; MALE; PAIN; RESPIRATORY TRACT INFECTION; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; TENDINITIS; ULTRASOUND;

EID: 0035159603     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03173892     Document Type: Article

References (10)

1. Clinical use of the fluoroquinolones
2. Toxicity of quinolones
3. The next generation: Fluoroquinolones in the management of acute lower respiratory infection in adults
4. Fluoroquinolone-induced tendiopathy: What do we know?
5. Achilles tendonitis and tendon rupture due to fluoroquinolone antibiotics
6. Community-acquired pneumonia in adults: Guidelines for management
7. Levofloxacin-induced bilateral Achilles tendonitis
8. The effect of ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism
9. Pathology of Achilles tendon in association with ciprofloxacin treatment
10. Guidelines for management of adult community-acquired lower respiratory infections